trending Market Intelligence /marketintelligence/en/news-insights/trending/iaw4z7jmjbi_zsgvzc7dkg2 content esgSubNav
In This List

Catalyst Pharmaceuticals names chief commercial officer

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Catalyst Pharmaceuticals names chief commercial officer

Catalyst Pharmaceuticals Inc. appointed Daniel Brennan as chief commercial officer.

Brennan will lead the biopharmaceutical company's marketing, sales and commercial operations. He most recently served as COO at Edge Therapeutics Inc.